These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Utrogestan--an alternative for synthetic gestagen treatment in spontaneous abortion]. Nalbanski B; Tsekova K; Ivanov S; Kostov I Akush Ginekol (Sofiia); 2002; 41(4):11-3. PubMed ID: 12516253 [TBL] [Abstract][Full Text] [Related]
6. [Syndrome due to estrogen-progestogens in a worker engaged in the production of contraceptive agents]. Gambini G; Farina G; Arbosti G Med Lav; 1976; 67(2):152-7. PubMed ID: 1021708 [No Abstract] [Full Text] [Related]
7. Letter: Birth defects and oestrogens and progesterones in pregnancy. Harlap S; Prywes R; Davies AM Lancet; 1975 Mar; 1(7908):682-3. PubMed ID: 47104 [No Abstract] [Full Text] [Related]
10. Proceedings of the symposium "progesterone, progestins, and fetal development". Chez RA Fertil Steril; 1978 Jul; 30(1):16-26. PubMed ID: 680179 [No Abstract] [Full Text] [Related]
11. Hormonal versus genetic factors in limb and heart anomalies. el-Gindi E; Ahmed-Nasr M Cardiovasc Surg; 1993 Aug; 1(4):381-3. PubMed ID: 8076064 [TBL] [Abstract][Full Text] [Related]
12. [Oral contraceptives and thromboembolism (author's transl)]. Sato K; Ogino M; Nakabayashi M; Sakamoto S Kokyu To Junkan; 1978 Mar; 26(3):212-20. PubMed ID: 349637 [No Abstract] [Full Text] [Related]
13. First-trimester exposure to progestagen/oestrogen and congenital malformations. Goujard J; Rumeau-Rouquette C Lancet; 1977 Feb; 1(8009):482-3. PubMed ID: 65583 [No Abstract] [Full Text] [Related]
14. Exogenous sex hormone exposure and the risk for major malformations. Lammer EJ; Cordero JF JAMA; 1986 Jun; 255(22):3128-32. PubMed ID: 3702023 [TBL] [Abstract][Full Text] [Related]
15. [Lipid metabolism disorders and increased vascular risk due to contraceptive steroids]. Basdevant A; de Lignieres B; Mauvais-Jarvis P Nouv Presse Med; 1976 Apr; 6(17):1469-72. PubMed ID: 1025526 [No Abstract] [Full Text] [Related]
17. [Oral hormone therapy in the pre- and postmenopausal period]. Braendle W; Bettendorf G Gynakologe; 1986 Dec; 19(4):235-40. PubMed ID: 3817595 [No Abstract] [Full Text] [Related]
18. [Choice of a progestagen in ovulatory dysfunction]. Bruhat MA Ann Endocrinol (Paris); 1979; 40(3 Suppl):362-6. PubMed ID: 496383 [No Abstract] [Full Text] [Related]
19. [Intake of estroprogestins in pregnancy and hypospadias]. Milia S; Firinu C; Piras G; Lo Dico G; Stoppelli I Minerva Ginecol; 1982 Dec; 34(12):1023-7. PubMed ID: 7155433 [No Abstract] [Full Text] [Related]